Chloroquine-induced cardiomyopathy: a reversible cause of heart failure
- PMID: 29460476
- PMCID: PMC5933951
- DOI: 10.1002/ehf2.12276
Chloroquine-induced cardiomyopathy: a reversible cause of heart failure
Abstract
Chloroquine (CQ) and hydroxychloroquine (HCQ) are anti-rheumatic medications frequently used in the treatment of connective tissue disorders. We present the case of a 45-year-old woman with CQ-induced cardiomyopathy leading to severe heart failure. Electrocardiographic abnormalities included bifascicular block, while structural disease consisted of severe biventricular and biatrial hypertrophy. Appropriate diagnosis via endomyocardial biopsy led to cessation of CQ and subsequent dramatic improvement in symptoms and structural heart disease. Cardiac toxicity is an under-recognized adverse effect of CQ/HCQ leading to cardiomyopathy with concentric hypertrophy and conduction abnormalities, with the potential for significant morbidity and mortality. Predisposing factors for CQ/HCQ-induced cardiomyopathy have been proposed. CQ/HCQ cardiomyopathy is a phenocopy of Fabry disease, and α-galactosidase A polymorphism may account for some heterogeneity of disease presentation.
Keywords: Cardiac MRI; Cardiomyopathy; Chloroquine; Heart failure.
© 2018 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of the European Society of Cardiology.
Figures
References
-
- Page RL, O'Bryant CL, Cheng D, Dow TJ, Ky B, Stein CM, Spencer AP, Trupp RJ, Lindenfeld J. Drugs that may cause or exacerbate heart failure. Circulation 2016; 134: e32‐e69. - PubMed
-
- Eschenhagen T, Force T, Ewer MS, Keulenaer GW, Suter TM, Anker SD, Avkiran M, Azambuja E, Balligand JL, Brutsaert DL. Cardiovascular side effects of cancer therapies: a position statement from the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 2011; 13: 1–10. - PubMed
-
- Yogasundaram H, Putko BN, Tien J, Paterson DI, Cujec B, Ringrose J, Oudit GY. Hydroxychloroquine‐induced cardiomyopathy: case report, pathophysiology, diagnosis, and treatment. Can J Cardiol 2014; 30: 1706–1715. - PubMed
-
- Ferrari R, Böhm M, Cleland JG, Paulus WJ, Pieske B, Rapezzi C, Tavazzi L. Heart failure with preserved ejection fraction: uncertainties and dilemmas. Eur J Heart Fail 2015; 17: 665–671. - PubMed
-
- Tselios K, Gladman DD, Harvey P, Mak S, Chantal M, Butany J, Urowitz MB. Hydroxychloroquine‐induced cardiomyopathy in systemic lupus erythematosus. J Clin Rheumatol: Practical Reports on Rheumatic & Musculoskeletal Diseases 2016; 22: 287–288. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
